U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300683) titled 'Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma' on Sept. 15.
Brief Summary: The goal of this clinical trial is to learn if anti-CCR9 CAR T cells (which will be made using the patient's own blood cells) are safe and which dose should be used in children and adults with T cell leukaemia and lymphoma.
Participants will:
* have T cells collected from their blood and these T cells will be used to make the CAR-T cells in a specialized laboratory.
* be admitted at the hospital a week before the CAR T cells infusion to receive a short course of chemotherapy drugs which prepare the body to receive the CAR T cells.
* be given the CAR...